Russell Alan J's Form 4 filing
Edgewise Therapeutics, Inc. (EWTX) · filed Dec 31, 2024
- Accession no.
- 0001562180-24-008663
- Filed
- Dec 31, 2024, 5:13 PM ET
- Trade date
- Dec 30, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $2.74M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Russell Alan JCIK 0001853529 | Director, Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 30, 2024 | Common Stock | MOption exerciseAcquired | +100,000 | $0.18 | +$18,000 | 114,863 | Direct | |
| Dec 30, 2024 | Common Stock | SSaleDisposed | −100,000 | $27.37 | −$2,737,470 | 14,863 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 30, 2024 | Common Stock | MOption exerciseDisposed | −100,000 | $0.00 | $0 | 1,356,780 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.